Updated November 2026
If you are considering medical weight loss, you have probably heard about semaglutide and tirzepatide. Both help manage appetite and blood sugar, but they target different pathways in the body:
- Tirzepatide: Works as a dual-action therapy targeting two natural gut hormone receptors (GIP and GLP-1). This dual approach helps improve how your body handles sugar while significantly reducing hunger.
- Semaglutide: Works as a single-action therapy targeting the GLP-1 receptor. It slows down digestion and signals to your brain that you are full, helping you eat less without constant cravings.
Benefits:
Tirzepatide:
- Mechanism: Dual GIP and GLP-1 receptor co-agonist.
- Clinical Trial Outcomes: Average body-weight reduction of up to 20.9%–22.5% at top maintenance doses in clinical trials with lifestyle interventions.
- Metabolic Benefits: Dual hormonal action that enhances feeling of fulness and improves glucose regulation.
- Ideal Candidate Consideration: Often recommended for individuals who need extra metabolic help, or for those whose weight loss has stalled on other medications.
Semaglutide:
- Mechanism: Selective single GLP-1 receptor agonist.
- Clinical Trial Outcomes: Average body-weight reduction of approximately 15% in pivotal clinical trials when combined with lifestyle modifications.
- Metabolic Benefits: Slows digestion, minimizes hunger signals, and stabilizes blood sugar spikes.
- Ideal Candidate Consideration: An established, well-studied therapy with broad clinical documentation across both cardiovascular and metabolic health.
Which Incretin Therapy Fits Your Health Profile?
Choosing between semaglutide and tirzepatide comes down to your personal biology and health priorities:
- Tirzepatide utilizes dual-hormone receptor activity (GIP and GLP-1), which delivered higher average weight-reduction percentages in clinical trials. It is often a strong candidate for patients needing robust metabolic intervention.
- Semaglutide offers a well-established clinical history as a selective GLP-1 receptor agonist, backed by robust data for metabolic health and long-term cardiovascular risk reduction.
- Tolerability & Comfort: Common side effects for both medications involve temporary gastrointestinal adjustments (such as nausea or constipation) that typically resolve as your body adapts. Individual responses vary, making personalized dosing and dietary guidance essential.
The right prescription is never one-size-fits-all. Dr. Fortino tailors every protocol through in-person clinical evaluations, ongoing monitoring, and structured nutritional support.
Want to learn more or get started? We’re here to help! Contact our office to schedule a consultation. Together, we can create a personalized plan to meet your weight loss goals.
Interested in learning more? Contact us.
Medical Disclaimer: The clinical information presented here is for educational purposes only and does not constitute individualized medical advice, clinical diagnosis, or a guaranteed treatment outcome. Prescriptions and treatment protocols for semaglutide or tirzepatide are determined solely at the physician’s discretion following an in-person medical evaluation by Dr. Robert Fortino. Compounded medications, when clinically indicated for documented individualized patient needs, are prepared by state-licensed compounding pharmacies and are not FDA-approved drugs or generic equivalents